ExodusPoint Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,699
| Closed | -$85K | – | 1601 |
|
|
2025
Q1 | $85K | Buy |
+38,699
| New | +$85K | ﹤0.01% | 1293 |
|
|
2023
Q1 | – | Sell |
-423,898
| Closed | -$1.06M | – | 1815 |
|
|
2022
Q4 | $1.06M | Buy |
423,898
+10,286
| +2% | +$25.7K | 0.02% | 892 |
|
|
2022
Q3 | $1.75M | Buy |
413,612
+281,359
| +213% | +$1.19M | 0.02% | 828 |
|
|
2022
Q2 | $369K | Sell |
132,253
-35,249
| -21% | -$98.3K | ﹤0.01% | 1409 |
|
|
2022
Q1 | $958K | Buy |
167,502
+100,039
| +148% | +$572K | 0.01% | 1129 |
|
|
2021
Q4 | $616K | Buy |
+67,463
| New | +$616K | 0.01% | 1253 |
|
|
2021
Q2 | – | Sell |
-26,627
| Closed | -$432K | – | 2468 |
|
|
2021
Q1 | $432K | Buy |
+26,627
| New | +$432K | 0.01% | 1422 |
|
|
2020
Q4 | – | Sell |
-62,210
| Closed | -$922K | – | 2048 |
|
|
2020
Q3 | $922K | Sell |
62,210
-7,696
| -11% | -$114K | 0.02% | 666 |
|
|
2020
Q2 | $1.03M | Buy |
+69,906
| New | +$1.03M | 0.03% | 710 |
|